PubMed ·

Average daily ischemic and bleeding risk following acute coronary syndrome: Insights from the FORCE-ACS registry.

Jaouad Azzahhafi, Dean R P P Chan Pin Yin, Niels M R van der Sangen, Wout W A van den Broek, Shabiga Sivanesan, Qiu Ying F van de Pol, Ronald J Walhout, Melvyn Tjon Joe Gin, Ron Pisters, Deborah M Nicastia, Jorina Langerveld, Georgios J Vlachojannis and 5 others

Published
Source
PubMed
Original
Read it at PubMed
Topics
Cardiology

In brief

Understanding Ischemic vs. Bleeding Risks Post-ACS

This study sheds light on the average daily ischemic rate (ADIR) and average daily bleeding rate (ADBR) over three years post-ACS, revealing that bleeding events are more frequent than ischemic events, particularly in the early stages.

What they found: The study found that during the first three years post-ACS, there were 929 ischemic events and 1,694 bleeding events among the participants. The average daily bleeding rate was significantly higher than the ischemic rate, particularly in the acute phase (1.41 vs 0.68). Overall, the bleeding events outnumbered ischemic events, especially in the first year, highlighting the need for careful monitoring of bleeding risks in ACS patients.

AI-written summary, not medical advice. Check anything you rely on against the original paper.

From the abstract

To characterize ischemic and bleeding events and compare the average daily ischemic rate (ADIR) and average daily bleeding rate (ADBR) during three years post-ACS. Data were derived from ACS patients enrolled in the prospective multicenter FORCE-ACS registry in nine Dutch hospitals between 2015 and 2019.

The opening of the authors’ abstract. The rest is with PubMed.

Read the full abstract at PubMed

Read it on ReadSearch

Each opens after you create an account, and brings you back to this paper.

Already a reader? Sign in

All new papers in Cardiology

Get the few papers worth your time in Cardiology every morning.

ReadSearch reads the new papers in your field each day and brings you the few worth reading, each with its key finding in a sentence.

Papers belong to their authors and publishers; every page here links to the original. All research topics